The Reliability of the Box and Block Test in People After Stroke
Launched by CHARLES UNIVERSITY, CZECH REPUBLIC · Aug 14, 2021
Trial Information
Current as of May 14, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a test called the Box and Block Test, which is used to measure how well people can move their hands after having a stroke. The main goal of the study is to see how reliable this test is when administered according to a new set of guidelines in Czech. The researchers want to make sure that the test results are consistent and trustworthy.
To participate in the trial, you need to be an adult who speaks Czech and has had a stroke. You should also be able to move small blocks a certain distance and complete the test three times while sitting for about 20 minutes. However, if you have severe vision or hearing problems, or if you're taking medications that affect your attention, you may not be eligible to join. If you decide to participate, you'll help researchers understand how effective this test is for assessing hand movement in stroke patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Czech language as a mother tongue
- • Adult (age 18 and more)
- • Patient after Stroke attending the Department of Rehabilitation Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague
- • Able to move 25mm X 25mm block at least by 10 cm
- • Able to complete testing with full 3 attempts
- • Able to sit for 20 minutes
- Exclusion Criteria:
- • use of drugs affecting attention
- • vision impairment uncorrectable with glasses
- • severe hearing loss
- • inability to understand instructions
- • inability to complete testing
- • failure to sign Informed consent for probation with inclusion to research and Consent to the collection and processing of personal data during the study at the General University Hospital in Prague
About Charles University, Czech Republic
Charles University, located in the Czech Republic, is a prestigious institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive academic expertise and state-of-the-art facilities to conduct innovative research that aims to improve patient outcomes and contribute to the global medical community. With a focus on ethical standards and rigorous scientific methodologies, Charles University collaborates with various stakeholders to explore new therapies and enhance healthcare practices, fostering a culture of excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Praha, , Czechia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials